Observational Study on Mortality and Outcome of Patients Hospitalized for Subarachnoid Hemorrhage of Aneurysmal Origin in Martinique Between 2013 and 2021
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Usual patient care for patients hospitalized for subarachnoid hemorrhage of aneurysmal origin.
- Who it may be relevant to
- Registry conditions: Subarachnoid Hemorrhage of Aneurysmal Cause. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Martinique
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The aim of our study is to analyze mortality and sequelae of subarachnoid hemorrhage of aneurysmal origin in hospitalized patients in Martinique. Predictive factors of poor prognosis will also be analyzed.
Detailed description
Subarachnoid hemorrhage is an uncommon pathology in the general population, with a worldwide incidence of 9 per 100,000 people/year, but with a non-negligible risk of sequelae in terms of impairments, activity limitations and participation restrictions of around 30%. Mortality remains high at 40%, despite increasingly specialized care.
In addition, there are a number of objective, rapid assessment scores for autonomy and impairments, notably the modified Rankin score, which is not specific to subarachnoid hemorrhage, but which enables the study of patients' perceived quality of life. Certain factors predictive of bad patient outcome are known in the literature, but have been little studied in the population of Martinique.
Interventions
- Other Usual patient care for patients hospitalized for subarachnoid hemorrhage of aneurysmal origin
During hospitalization (2013-2021), patients were managed after multidisciplinary consultation in accordance with national recommendations between resuscitators, neurosurgeons and neuroradiologists, depending on the severity of the initial management and the patient's comorbidities, either by interventional radiology, neurosurgery or medical treatment.
Primary outcome measures
- Evaluate mortality in patients hospitalized for subarachnoid hemorrhage of aneurysmal origin over a 9-year period (2013-2021) in Martinique. [Time frame: 6 months]
Secondary outcome measures (4)
- Evaluate the clinical outcome of these patients. [Time frame: 6 months]
- Analyze the factors associated with a significant impairment of autonomy and/or dependence. [Time frame: 6 months]
- Analyze the factors associated with death. [Time frame: 6 months]
- Analyze the factors associated with a poor prognosis (death AND/OR significant impairment of autonomy/dependence). [Time frame: 6 months]
Eligibility criteria
Inclusion criteria
- Adult (≥18 years) patients,
- Admitted to University Hospital of Martinique with subarachnoid hemorrhage of aneurysmal origin between 01/01/2013 and 31/12/2021,
- Informed patient/next-of-kin/treating physician consent for research participation.
Exclusion criteria
- Other causes of subarachnoid hemorrhage of non-aneurysmal origin (traumatic, arteriovenous malformation, cerebral tumor, cerebral thrombophlebitis).
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Martinique · 1 center
- University Hospital Center of Martinique — Fort-de-France
Identifiers
NCT: NCT06525012 · 24_RIPH3-01